Results 101 to 110 of about 153,478 (337)

Current practices in managing acutely disturbed patients at three hospitals in Rio de Janeiro-Brazil: a prevalence study [PDF]

, 2002
The medical management of aggressive and violent behaviour is a critical situation for which there is little evidence. In order to prepare for a randomised trial, due to start in the psychiatric emergency rooms of Rio de Janeiro in 2001, a survey of ...
Adams, C.E., Carvalho, A, Coutinho, E, Fagundes, H.M., Gewandszajder, M, Huf, G, Keusen, A, Lopez, J, Oliveira, E.S.   +8 more
core  

Benzodiazepines [PDF]

Journal of Pain and Symptom Management, 2014
Paul, Howard, Robert, Twycross, John, Shuster, Mary, Mihalyo, Andrew, Wilcock   +4 more
openaire   +2 more sources

“Epileptic seizure code in the region of Madrid”: A process‐based healthcare network for the acute management of epileptic seizures

Epilepsia Open, EarlyView.
Abstract The principle “time is brain” applies to epileptic seizures as well as stroke. Despite existing guidelines, delays in treatment initiation remain common. In 2020, we developed a consensus statement aiming to improve the acute management of emergency seizures and implement a “Seizure Code” (SC) in Madrid, Spain. A multidisciplinary group of 105
Irene García Morales, José M. Serratosa Fernández, Antonio Gil‐Nagel Rein, Navid Behzadi Koochani, Cesáreo Fernández Alonso, Esther Aleo Luján, Adrián García Ron, Alfonso Martín Martínez   +7 more
wiley   +1 more source

Benzodiazepines and risk of dementia – Is there a reason for alarm?

European Psychiatry
Introduction The population ageing is a reality associated with an increase in prevalence of Dementia. The use of benzodiazepines is often postulated as a risk factor in these syndromes.
R. P. L. Andrade, N. Castro, R. Vaz, J. Martins, J. Abreu, E. Almeida, I. Santos, F. Cunha, H. Afonso   +8 more
doaj   +1 more source

Gabapentin, Concomitant Prescription of Opioids, and Benzodiazepines among Kidney Transplant Recipients

, 2023
Yusi Chen, JiYoon B. Ahn, Sunjae Bae, Corey Joseph, Mark A. Schnitzler, Gregory P. Hess, Krista L. Lentine, Bonnie E. Lonze, Dorry L. Segev, Mara McAdams‐DeMarco   +9 more
openalex   +2 more sources

In‐hospital outcomes of lacosamide versus levetiracetam for early adjunctive treatment of status epilepticus: A Nationwide Japanese retrospective cohort study

Epilepsia Open, EarlyView.
Abstract Objective Status epilepticus (SE) is a neurological emergency requiring immediate treatment. Although intravenous lacosamide (LCM) is used for the management of epilepsy, its effectiveness in treating SE remains unclear. We aimed to compare the in‐hospital outcomes between intravenous LCM and levetiracetam (LEV) as an early adjunctive therapy ...
Yumiko Nakamura, Shotaro Aso, Hideo Yasunaga, Hiroki Matsui, Yuichiro Shirota, Masashi Hamada, Kiyohide Fushimi, Tatsushi Toda, Satoshi Kodama   +8 more
wiley   +1 more source

Peripheral Benzodiazepine Receptor/Translocator Protein Global Knock-out Mice Are Viable with No Effects on Steroid Hormone Biosynthesis [PDF]

, 2014
Lan N. Tu, Kanako Morohaku, Pulak R. Manna, Susanne H. Pelton, W.R. Butler, Douglas M. Stocco, Vimal Selvaraj   +6 more
openalex   +1 more source

Incidence and prehospital management of convulsive status epilepticus in Martinique, a French Caribbean territory

Epilepsia Open, EarlyView.
Abstract Objective Status epilepticus (SE) is an acute complication that can either occur in the course of epilepsy, or reflect an acute neurological or systemic disorder. SE incidence and associated mortality vary across regions and studied populations.
Florian Negrello, Alexis Fremery, Jonathan Florentin, Sylvie Merle, Vianney Aquilina, Yannick Brouste, Dabor Resiere, Rishika Banydeen, Papa Gueye   +8 more
wiley   +1 more source

Underdosing of Benzodiazepines in Patients With Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial [PDF]

, 2019
Abhishek G. Sathe, Holly Tillman, Lisa D. Coles, Jordan Elm, Robert Silbergleit, James M. Chamberlain, Jaideep Kapur, Hannah R. Cock, Nathan B. Fountain, Shlomo Shinnar, Daniel H. Lowenstein, Robin Conwit, Thomas P. Bleck, James C. Cloyd   +13 more
openalex   +1 more source

Stiripentol use in Dravet syndrome patients in the USA: Results of a real‐world study

Epilepsia Open, EarlyView.
Abstract Objective Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy with a high seizure burden and mortality risk. Stiripentol, one of the first DS‐specific therapies, received FDA approval in 2018 but its real‐world use and impact post‐approval in the USA remain insufficiently characterized.
Elaine Wirrell, James Wheless, Michael Scott Perry, Linda Laux, Karen C. Keough, Julie Ziobro, Aimee F. Luat, Gewalin Aungaroon, Michael A. Ciliberto, Roxane Noel, Laurent Chancharme, Joseph Sullivan   +11 more
wiley   +1 more source